Literature DB >> 553176

A coronary screening programme in general practice.

J S Brown.   

Abstract

All male patients between the ages of 37 and 43 were selected from an age-sex register and invited to attend the surgery for coronary screening, which included medical history, family history, occupation, smoking habits, blood pressure, examination of the urine, measurement of weight and height, the taking of an electrocardiogram and chest x-ray, plus fasting blood levels of cholesterol, sugar, triglycerides, lipid electrophoresis, urea, and full blood picture. Sixty-four per cent responded to the invitation and of those, avoidable risk factors were found in 52 per cent.Forty per cent of those reporting had not previously had their blood pressure recorded. Fifty-eight per cent had not had their urine examined, and 71 per cent had never had a chest x-ray.Twenty per cent were found to have atypical electrocardiograms (mainly T-wave changes and ectopics) and 20 per cent had sufficiently elevated plasma lipids to justify further electrophoresis. Forty-four per cent of patients admitted to smoking more than 10 cigarettes daily.Follow-up of the smokers one year later showed that 27 per cent had stopped smoking completely, 12 per cent had reduced their smoking by more than half, 54 per cent had not changed their smoking habits at all, five per cent had given up smoking but started again, and two per cent had either moved away or could not be traced.I believe such a programme can readily be undertaken in the average general practice and can yield much useful information, such that it is possible to influence patients' smoking habits by advice.

Entities:  

Mesh:

Year:  1978        PMID: 553176      PMCID: PMC2159006     

Source DB:  PubMed          Journal:  J R Coll Gen Pract        ISSN: 0035-8797


  8 in total

1.  Mortality among doctors in different occupations.

Authors:  R Doll; R Peto
Journal:  Br Med J       Date:  1977-06-04

2.  Smoking and the heart. The basis for action.

Authors:  K Ball; R Turner
Journal:  Lancet       Date:  1974-10-05       Impact factor: 79.321

3.  Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study.

Authors:  L A Carlson; L E Böttiger
Journal:  Lancet       Date:  1972-04-22       Impact factor: 79.321

4.  Semicontinuous screening of a whole community for hypertension.

Authors:  J T Hart
Journal:  Lancet       Date:  1970-08-01       Impact factor: 79.321

5.  A screening clinic for hypertension in general practice.

Authors:  J Coope
Journal:  J R Coll Gen Pract       Date:  1974-03

6.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

7.  Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. A twelve-year clinical trial in men and women.

Authors:  M Miettinen; O Turpeinen; M J Karvonen; R Elosuo; E Paavilainen
Journal:  Lancet       Date:  1972-10-21       Impact factor: 79.321

8.  The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study.

Authors:  N E Miller; D S Thelle; O H Forde; O D Mjos
Journal:  Lancet       Date:  1977-05-07       Impact factor: 79.321

  8 in total
  3 in total

1.  Screening for increased cardiometabolic risk in primary care: a systematic review.

Authors:  Corine den Engelsen; Paula S Koekkoek; Merijn B Godefrooij; Mark G Spigt; Guy E Rutten
Journal:  Br J Gen Pract       Date:  2014-10       Impact factor: 5.386

2.  Coronary heart disease: account of a preventive clinic in general practice.

Authors:  J G Wrench; R Irvine
Journal:  J R Coll Gen Pract       Date:  1984-09

3.  Invitation to attend a health check in a general practice setting: comparison of attenders and non-attenders.

Authors:  R Pill; J French; K Harding; N Stott
Journal:  J R Coll Gen Pract       Date:  1988-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.